Enterome vs Moleculent
Enterome vs Moleculent, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Moleculent on 61/100.
Where each one leads
Enterome
- domain rating: 46/100 against 36/100
- funding raised: $124M against $46.0M
- LinkedIn following: 16,846 against 345
Moleculent
- agent readiness: 47/100 against 21/100
- headcount: 64 against 33
At a glance
| Measure | Enterome | Moleculent |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Mapping cell-cell communication at scale in human tissue. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotech, Life Sciences, Genomics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2012 | 2019 |
| Headquarters | Paris, France | Stockholm, Sweden |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | Moleculent |
|---|---|---|
| Employees | 33 | 64 |
| Total funding | $124M | $46.0M |
| Latest round | Later Stage VC | Series B |
| LinkedIn followers | 16,846 | 345 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | Moleculent |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 61/100 |
| Traction | 55/100 | 56/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 34/100 | 37/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 36/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | Moleculent |
|---|---|---|
| Hosting | Self Managed | AWS |
| CMS | WordPress | WordPress |
| Frameworks | Bootstrap | Tailwind CSS |
| Analytics | Google Analytics 4, Segment | Google Tag Manager |
| Support stack | Not detected | HubSpot |
Enterome vs Moleculent: common questions
Which is better, Enterome or Moleculent?
On our 0-100 score Moleculent rates higher (61/100 against 60/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Enterome and Moleculent compare on the numbers?
Enterome leads on domain rating (46/100 against 36/100), funding raised ($124M against $46.0M), LinkedIn following (16,846 against 345). Moleculent leads on agent readiness (47/100 against 21/100), headcount (64 against 33).
Read the full Enterome review and pricing or the Moleculent review and pricing. You can also browse other Enterome alternatives we track.